FRANKLIN LAKES, N.J.--(BUSINESS WIRE)--ReGen Biologics (OTCBB: RGBI) will attend the annual meeting of the American Orthopaedic Society for Sports Medicine (AOSSM), being held this week in Calgary, Canada. The company will exhibit the CMI™ collagen meniscus implant, which is CE marked and cleared for sale in Europe for both medial and lateral use.
